Venture capital SPV

Gaingels Healthcare I SPV

Invest now
Alto Marketplace’s offerings are currently available only to accredited investors.

Venture capital SPV

Gaingels Healthcare I SPV

Alto Marketplace’s offerings are currently available only to accredited investors.

Alto Capital’s SPV will invest in the Gaingels Healthcare Fund I, a venture capital fund focused on investing in healthcare companies. This investment aims to support companies that may have a positive impact on the LGBTQ+ community.

Offering details

Offering name:
Gaingels Healthcare I SPV
Minimum investment size:
Type of offering:
Investor type:
Accredited investors
Launch date:
June 4, 2024
The SPV charges a 2% upfront management fee, and an additional 0.25% (25 basis points) annual fee will be applied.*
Anticipated final close:
Rolling monthly close thru December 2024
Asset Class:
Venture capital SPV
*The SPV will collect a 4.50% upfront fee, which will be held in reserve. For a detailed breakdown of additional fees and expenses associated with the underlying Fund, please refer to the offering documents.

Upcoming Webinar

June 24th at 4:00 pm CT
Join leaders from Alto Securities and Gaingels to hear them discuss a unique investment opportunity on Alto Marketplace.
Register here

About the investment

Gaingels Healthcare Fund I

Targeting Seed to Series B venture investments, the Gaingels Healthcare Fund I aims to raise $10M to invest in early-stage healthcare companies. This fund seeks to support companies that may drive healthcare inclusivity for the LGBTQ+ community.

According to research by Gallup1, the LGBTQ+ community has more than doubled over the last decade. Within the newly-adult Gen Z demographic, approximately 20% identify as LGBTQ+, signaling the potential for meaningful growth in the target demographic.

This increasing population poses an imminent challenge, given that according to the National LGBT Health Education Center2, members of this community can encounter difficulties accessing quality healthcare. Surveying in 2018 by the Center for American Progress3 found that nearly 10% of respondents had a doctor or medical service provider refuse them care due to their orientation and even more avoid care due to concerns over cultural and clinical competency of their providers.

Fund strategy

The Gaingels Healthcare Fund I Investment Committee intends to allocate the Fund across 25 to 30 investments in early-stage healthcare companies, with 30% reserved for follow-on investing.

The Gaingels Healthcare Fund aims to add value to portfolio companies through a $5M partnership with Eidos at The University of Pennsylvania4.

The Gaingels Healthcare Fund has already made five investments alongside top institutional investors including GV (FKA Google Ventures), Valor Ventures, M13, GreatPoint Ventures, SOSV, and Merck.

About Gaingels

Gaingels is a private investment syndicate, and one of the largest and most active private investors dedicated to supporting diversity and inclusion within the venture capital ecosystem to support LGBTQIA+/Allies communities.

Gaingels sponsors a Venture Inclusion Program that recruits diverse board members and company leadership, helps introduce VC to diverse investors, and has awarded $375,000 in scholarships to underrepresented students. The program also supports a Marketplace of minority-owned portfolio companies.

Meet the team


Investment Committee

Notable co-investors in Gaingels’ deals have included*:

*The sample co-investors listed are some that Gaingels have participated in rounds alongside, before, or after, and should not be taken as a  predictor of future co-investors for any given portfolio company. There is no guarantee of who will be the co-investors.

Alto Capital

Value creation for companies and their investors is increasingly private

According to 2022 data analysis by Dealroom5, over 70% ($7.5T) of the $11T of value creation by companies founded since 2012 was from companies that remained private at that time.

This is supported by research from the National Bureau of Economic Research6, which found that the total number of publicly traded companies in the United States fell from 8,000 to 4,100 from 1996 to 2012, while the rest of the world saw an increase from 30,700 to 39,400.

These figures indicate an increase in private market capital opportunities for businesses, and venture capital plays a key role in this space.

Gain exposure to venture capital by investing in Alto Capital’s Gaingels Healthcare-focused SPV

Alto aims to empower individuals with investment opportunities curated for long-term, retirement-oriented consideration. The alignment between alternative assets’ naturally longer-term maturation of value over time and the forward-looking nature of investing for retirement is an overlap in strategy we refer to as duration matching.

Upcoming Webinar

June 24th at 4:00 pm CT
Join leaders from Alto Securities and Gaingels to hear them discuss a unique investment opportunity on Alto Marketplace.
Register here

Watch our webinar

Missed our webinar? Tune in to the recording.
Watch webinar

Offering documents

Please log in or sign up to view additional Investment Documents for this offering.


*Please be aware that Alto Capital SPV charges an annual management fee upfront. Alto Capital reserves the right to waive this fee at its sole discretion. This fee is charged for the management and operation of the SPV and is separate from the fees associated with the underlying investment opportunity. Understanding that this management fee is an additional cost that will affect the overall return on your investment is crucial. Furthermore, the underlying fund also charges separate fees. These fees differ from the SPV's annual management fee and may impact your investment returns. To ensure you have a comprehensive understanding of all fees and charges that apply to your investment, we strongly encourage you to review the offering documents thoroughly. These documents provide detailed information on all fees, charges, and the terms of your investment.
Neither Alto Securities, LLC (“Alto Securities”) nor any of its affiliates provide any investment advice or make any investment recommendations to any persons, ever, and no communication herein or otherwise shall be construed as investment advice or a recommendation about any specific security offering, investment, asset, or fund.
Private securities are intended for highly sophisticated investors and involve substantial risks. These risks include but are not limited to a lack of operating history, leverage, liquidity of the portfolio, segregated portfolio fund risk, diversification and concentration risk, and long-term investment risk. Past performance does not indicate future results; all investments carry inherent risks. Diversification does not eliminate risk, and returns on investments are not guaranteed. It is advisable to consult with financial professionals and conduct due diligence before making a decision. Furthermore, there is a risk that investors may receive little or no return on their investment or may lose part or all of their investment. However, there can be no assurance that the managers will successfully achieve the investment objective offered or deliver positive returns.
Investing in private securities carries a high risk and is considered speculative. Private securities are illiquid and do not trade like public markets. Illiquidity can result in investors having to sell their private securities at a price lower than their initial investment. This may lead to realized losses when exiting a position, and investors should be prepared for this possibility. An offering's investment objectives are not guaranteed to succeed under all market conditions. A fund's interest income may be affected by various factors, including investment performance, realized and projected market returns, fluctuations in market interest rates, and other pertinent factors.
Concerning any reference to high-net-worth individuals and institutions, it is essential to note that these investors often have substantial financial resources and longer investment horizons, which may differ from those of individual investors. Before participating in these opportunities, potential investors should carefully consider their financial circumstances, risk tolerance, and investment objectives. 
Alto Securities, LLC (“Alto Securities”) is a member of FINRA/SIPC.
Alto Securities, LLC serves as the placement agent for the fund's offering and will be compensated based on the investments made in the fund.
Check the background of Alto Securities, LLC on FINRA BrokerCheck.
Alto®, The Alternative IRA®, the Alto logo and Alto CryptoIRA® are trademarks of AltoIRA. All other trademarks are the properties of their respective owners. IRA services provided by Alto Solutions, Inc. and Alto Trust Co., custodian. Terms apply. Privacy Terms of Service Legal Terms
Alto Securities

Gaingels Healthcare I SPV


Minimum investment
ClosedInvest now
Get in touch
We are here to help.